Chromatin Bioscience is pleased to announce an ongoing research collaboration with Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback